Advances in adjuvant chemotherapy for colon cancer
Nelson, H.
Minerva Chirurgica 47(5): 213-222
1992
ISSN/ISBN: 0026-4733 PMID: 1594115 Document Number: 399640
Document emailed within 1 workday
Related Documents
Raskov, H.H. 1996: Adjuvant systemic chemotherapy in colon cancer Ugeskrift for Laeger 158(9): 1222-1227Fuchs, C.S.; Mayer, R.J. 1995: Adjuvant chemotherapy for colon and rectal cancer Seminars in Oncology 22(5): 472-487
Yaich, A.; Khanfir, A.; Bayrouti, M.I.; Frikha, M. 2015: Adjuvant chemotherapy in colon cancer. about 119 cases La Tunisie Medicale 93(4): 242-247
Fujinaka, R.; Otowa, Y.; Yokoo, H.; Arai, K.; Murata, K.; Mii, Y.; Kakinoki, K.; Oka, S.; Kuroda, D. 2019: Adjuvant Chemotherapy for High-Risk Stage Ⅱ Colon Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(8): 1327-1329
Miyake, Y.; Ikeda, K.; Osawa, H.; Nagase, H.; Hoshi, M.; Doi, T.; Makari, Y.; Oshima, S.; Iijima, S.; Kurokawa, E.; Kikkawa, N. 2012: Fluoropyrimidines with oxaliplatin(L-OHP) as an adjuvant chemotherapy for Stage IIi colon cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(12): 2161-2163
Matsuda, C.; Tamagawa, H.; Nishikawa, K.; Deguchi, T.; Kawata, J.; Iwase, K.; Takagi, M.; Fukui, A.; Nezu, R.; Tanaka, Y. 2013: Study of tolerability of capecitabine in postoperative adjuvant chemotherapy in colon cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(3): 327-330
Toshima, T.; Kodera, M.; Yamashita, Y.; Oishi, M.; Seshimo, K.; Yamamura, M.; Kato, H.; Ikeda, H.; Mizuno, K. 2013: A case in which dihydropyrimidine dehydrogenase deficiency was strongly suspected during adjuvant chemotherapy with capecitabine for colon cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(11): 1549-1552
Tomizawa, K.; Hanaoka, Y.; Toda, S.; Moriyama, J.; Matoba, S.; Kuroyanagi, H.; Hashimoto, M.; Udagawa, H.; Watanabe, G. 2013: A retrospective study of UFT and oral leucovorin combination adjuvant chemotherapy for patients over 76 years old with stage III colon cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(7): 881-885
Ichihashi, H.; Yamauchi, M.; Watanabe, T.; Takagi, H.; Kondo, T. 1988: Prospective adjuvant chemotherapy of mitomycin C plus HCFU for colorectal cancer (2d report)--6-year survival after surgery: Tokai Cooperative Study Group of Surgical Adjuvant Chemotherapy Gan no Rinsho. Japan Journal of Cancer Clinics 34(4): 451-456
Mitomi, T.; Tsuchiya, S.; Iijima, N.; Aso, K.; Suzuki, K.; Nishiyama, K.; Amano, T.; Takahashi, T.; Murayama, N.; Oka, H. 1989: Randomized controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. the Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(6): 2241-2249
Neoptolemos, J.P.; Baker, P.; Beger, H.; Link, K.; Pederzoli, P.; Bassi, C.; Dervenis, C.; Friess, H.; Büchler, M. 1997: Progress report. A randomized multicenter European study comparing adjuvant radiotherapy, 6-mo chemotherapy, and combination therapy vs no-adjuvant treatment in resectable pancreatic cancer (ESPAC-1) International Journal of Pancreatology: Official Journal of the International Association of Pancreatology 21(2): 97-104
Hotta, T.; Takifuji, K.; Arii, K.; Yokoyama, S.; Matsuda, K.; Higashiguchi, T.; Tominaga, T.; Oku, Y.; Yamaue, H. 2006: Clinical impact of adjuvant chemotherapy on patients with stage III colorectal cancer: l-LV/5FU chemotherapy as a modified RPMI regimen is an independent prognostic factor for survival Anticancer Research 26(2b): 1425-1432
Harvey, V.J. 1991: Adjuvant therapy of colon cancer: what should we be doing New Zealand Medical Journal 104(915): 280-281
Harvey, V.J. 1991: Adjuvant therapy of colon cancer: what should we be doing New Zealand Medical Journal 104(915): 280-281
Lee, J.J.; Chu, E. 2018: The Adjuvant Treatment of Stage IIi Colon Cancer: Might Less be More? Oncology 32(9): 437
Mamounas, E.P.; Wieand, H.S.; Jones, J.; Wickerham, D.L.; Wolmark, N. 1997: Future directions in the adjuvant treatment of colon cancer Oncology 11(9 Suppl 10: 44-47
Wils, J. 2001: Adjuvant therapy for colon cancer: the European experience Tumori 87(1 Suppl 1: S85
Shields, A.F. 2017: What is the optimal duration of adjuvant therapy in colon cancer? Clinical Advances in Hematology and Oncology: H&o 15(10): 734-738
Schlag, P.M. 1994: Adjuvant systemic chemo- or immunotherapy of colon cancer Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 65(6): 503-508
Kanoh, T.; Ohnishi, T.; Tono, T.; Takemoto, H.; Shiozaki, K.; Kimura, Y.; Iwazawa, T.; Nakano, Y.; Yano, H.; Monden, T. 2006: A case of successfully treated unresectable multiple liver metastases from colon cancer by hepatic arterial infusion chemotherapy and systemic chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(12): 1953-1955